Haplogen, founded 2010 is a Vienna based, privately owned biotechnology company. Based on a novel mechanism Haplogen develops proprietary small molecule therapeutic compounds for the treatment of diseases that lead to adipositas and obesity.
R&D:adipositas and obesity
Campus Vienna Biocenter 3
1030 Wien
Wien
Contact: Georg Casari (CEO)
Email: office@haplogen.com
Website